ESOMEPRAZOLE MAGNESIUM - esomeprazole magnesium capsule, delayed release
Family Dollar Stores, LLC
----------
Active ingredient (in each capsule)
*Esomeprazole 20 mg
(Each delayed-release capsule corresponds to 21.75 mg esomeprazole magnesium dihydrate USP)
Allergy alert:
■ Do not use if you are allergic to esomeprazole.
■ Esomeprazole may cause severe skin reactions.
Symptoms may include: ■ Skin reddening ■ blisters ■ rash. If an allergic reaction occurs, stop use and seek medical help right away.
These may be signs of a serious condition. See your doctor.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
14-Day Course of Treatment
Repeated 14-Day Courses (if needed)
Other information
colloidal silicon dioxide, FD&C blue no.1, gelatin, hydroxypropyl cellulose, hypromellose, magnesium carbonate, magnesium oxide, methacrylic acid and ethyl acrylate copolymer dispersion, mono and di glycerides, polysorbate 80, propylene glycol, shellac, sodium lauryl sulfate, strong ammonia solution, sugar spheres (which contains liquid glucose, starch (maize) and sucrose), talc, titanium dioxide, triethyl citrate and yellow iron oxide.
Questions or comments?
call 1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
DISTRIBUTED BY: MIDWOOD BRANDS, LLC
500 VOLVO PKWY, CHESAPEAKE, VA 23320 USA
Made in India
Code: TS/DRUGS/22/2009
FAMILY
Wellness™
ESOMEPRAZOLE
MAGNESIUM
Delayed-Release Capsules USP, 20 mg*
Acid Reducer 24
HOUR
Treats Frequent Heartburn CAPSULES
May take 1 to 4 days for full effect
14 CAPSULES
ONE 14-DAY COURSE OF TREATMENT
NDC 55319-051-05
FAMILY
Wellness
See new warning information
COMPARE TO
NEXIUM® 24 HR
ACTIVE INGREDIENT
ESOMEPRAZOLE
MAGNESIUM 24
Delayed-Release Capsules USP, 20 mg* HOUR
Acid Reducer
Treats Frequent Heartburn
May take 1 to 4 days for full effect
14 CAPSULES ACTUAL SIZE
ONE 14-DAY COURSE OF TREATMENT
NDC 55319-051-05
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium capsule, delayed release |
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Family Dollar Stores, LLC (024472631) |
Registrant - Aurohealth LLC (078728447) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aurobindo Pharma Limited | 650381903 | ANALYSIS(55319-051) , MANUFACTURE(55319-051) |